The Latest Research on CDK 4/6 Inhibitors
Learn about new CDK 4/6 inhibitor research in different breast cancer subtypes, including HER2+ and triple-negative MBC.
Read More
PAST ARTICLES
2022
2021
- Metastatic Breast Cancer News from 2021 ESMO
- Metastatic Breast Cancer News from ASCO 2021
- Update on Oral SERDs for Estrogen Receptor-Positive MBC
- MBC News from 2021 AACR Meeting
- St. Gallen International Breast Cancer Conference 2021
- Update on Hormone Receptor-Positive MBC
- What is Next-Generation Sequencing?
- Lines of Therapy: New Drugs May Change MBC Treatment
SEARCH OUR SITE
for past articles or specific information.